Stock Yards Bank & Trust Co. reduced its position in shares of MetLife, Inc. (NYSE:MET – Free Report) by 5.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,804 shares of the financial services provider’s stock after selling 374 shares during the period. Stock Yards Bank & Trust Co.’s holdings in MetLife were worth $561,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. PFG Investments LLC grew its stake in shares of MetLife by 8.9% in the third quarter. PFG Investments LLC now owns 6,360 shares of the financial services provider’s stock valued at $525,000 after acquiring an additional 520 shares in the last quarter. B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in shares of MetLife in the third quarter valued at approximately $2,960,000. Segall Bryant & Hamill LLC bought a new stake in shares of MetLife in the third quarter valued at approximately $1,074,000. Legal & General Group Plc raised its holdings in MetLife by 5.4% in the 2nd quarter. Legal & General Group Plc now owns 5,299,800 shares of the financial services provider’s stock valued at $371,993,000 after acquiring an additional 269,246 shares in the last quarter. Finally, AIA Group Ltd raised its stake in MetLife by 101.4% in the third quarter. AIA Group Ltd now owns 13,539 shares of the financial services provider’s stock valued at $1,117,000 after purchasing an additional 6,818 shares in the last quarter. 94.99% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of brokerages have recently weighed in on MET. Morgan Stanley cut their price target on shares of MetLife from $86.00 to $85.00 and set an “overweight” rating for the company in a report on Monday, August 19th. Piper Sandler lifted their price target on MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a research note on Wednesday, October 2nd. Jefferies Financial Group upped their price objective on MetLife from $89.00 to $95.00 and gave the stock a “buy” rating in a research report on Friday, September 27th. Wells Fargo & Company boosted their target price on MetLife from $92.00 to $93.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 5th. Finally, StockNews.com upgraded shares of MetLife from a “hold” rating to a “buy” rating in a research note on Monday, November 25th. Fourteen equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, MetLife presently has a consensus rating of “Buy” and a consensus target price of $88.62.
MetLife Trading Up 3.6 %
NYSE MET opened at $83.22 on Friday. The business’s 50-day moving average price is $83.75 and its two-hundred day moving average price is $77.22. MetLife, Inc. has a 12 month low of $64.61 and a 12 month high of $89.05. The firm has a market capitalization of $57.62 billion, a PE ratio of 16.78, a price-to-earnings-growth ratio of 0.74 and a beta of 1.06. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51.
MetLife Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Tuesday, November 5th will be paid a $0.545 dividend. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.62%. The ex-dividend date is Tuesday, November 5th. MetLife’s dividend payout ratio is currently 43.95%.
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Articles
- Five stocks we like better than MetLife
- Top Biotech Stocks: Exploring Innovation Opportunities
- 3 Small-Cap Stocks With Big Growth Potential
- What is the Hang Seng index?
- WallStreetBets: How a Reddit Forum Shook Up Stock Market Dynamics
- 3 Monster Growth Stocks to Buy Now
- Are 2024’s Top Insider Buys a Good Bet for 2025?
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.